For individual biomarkers, the overall cancer risk significantly escalated as the blood CRP (HR=1.036, 95% CI: (1.017-1.054)) and GLO (HR=1.128, 95% CI: (1.105-1.152)) levels increased, and as HEMO (HR=0.863, 95% CI: (0.842-0.884)), ALB (HR=0.846, 95% CI: (0.829-0.863)) and PLA (HR=0.842, 95% CI: (0.827-0.858)) levels decreased. This evidence concerns the gene ALB and cancer.